Immediate versus delayed surgical reconstruction for bone defects around dental implants
Official title: Immediate Versus Delayed Surgical Reconstruction of Peri-implantitis Intra-bony Defects: A Parallel-arm, Assessor-blind, Randomized, Controlled Clinical Trial
Run by University of Michigan · NCT07325747 · Data updated 2026-11-12
This trial will test whether doing bone grafting and membrane placement right away or waiting and doing it after initial healing works better for adults with peri-implantitis-related intra-bony defects around dental implants.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Drugs / interventions | radiation, prednisone |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | January 12, 2026 |
| Main results expected | February 2027 |
| Study ends | December 2028 |
| Registry record updated | February 6, 2026 |
| Trial ID | NCT07325747 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥18) in good general health who keep good oral hygiene, have an implant in function for at least one year with clinical peri-implantitis, and show an intra-bony defect at least 3 mm deep and no wider than 4 mm.
✕Probably not a fit
Patients with only mucositis (soft-tissue inflammation), very large or non-intrabony defects, poor oral hygiene, uncontrolled systemic disease, or who cannot attend follow-up visits are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with peri-implantitis and intra-bony defects will receive either simultaneous debridement and regeneration at the same visit (control) or a staged approach with initial decontamination followed by delayed guided bone regeneration (test). Both approaches use a compound allogenic bone graft mixture and a non-resorbable barrier membrane, and outcomes will be measured clinically, radiographically, histologically, volumetrically, microbiologically, and with patient-reported measures. Eligible participants are systemically healthy adults who maintain good oral hygiene, have an implant in function for at least one year, and present an intra-bony defect ≥3 mm deep and ≤4 mm wide. The trial aims to see if delayed regeneration leads to better hard-tissue fill and improved patient-centered outcomes compared with the conventional simultaneous procedure.
Why it matters
Potential benefit: If successful, the delayed approach could produce greater bone regeneration around implants and improve patient comfort and satisfaction after peri-implantitis surgery.
How similar studies have gone: Guided bone regeneration and grafting for peri-implant bone defects have shown moderate success in prior studies, but direct comparisons of immediate versus delayed reconstruction are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Systemically healthy adults * Age ≥ 18 years * The patient must be able to perform good oral hygiene * With at least one implant with either cement or a screw-retained prosthesis demonstrating a diagnosis of peri-implantitis at an implant in function for a minimum of 1 year with a prosthesis installed. * In cases where previous radiographic records are available: presence of bleeding and/or suppuration on gentle probing, increased probing depth compared to previous examinations, and radiographic evidence of bone loss beyond initial crestal remodeling. (Berglundh 2018). * In cases where baseline radiographs are not available: presence of PPD ≥6 mm with BOP and/or suppuration (SUP) and radiographically detectable marginal bone loss (MBL) exceeding 3 mm on an implant in function forfor at least 1 year (Berglundh 2018). * Target implants have to also demonstrate the presence of a peri-implant intra-bony defect with a depth ≥3 mm and width ≤4 mm, as assessed on radiographs and confirmed intra-surgically. In addition, the bony defect should present with a minimum of two walls . No implant mobility and no evidence of occlusal overload. In patients presenting with more than one implant meeting the inclusion criteria, a single implant will be randomly selected for inclusion in the study. Exclusion Criteria: * Short implants (≤ 6mm) * Contraindications for undergoing oral surgery. * Patients pregnant or attempting to get pregnant (self-reported), or nursing women. * Untreated/active periodontitis, or other untreated acute infections at the surgical site. * Untreated malignancies at the surgical site. * Self-reported current smoking, or active tobacco chewing, or chronic vaping. * Taking long-term (\>1yr) NSAID, prednisone or other anti-inflammatory prescription drugs * Patients with any known history of blood disorders or complications such as abnormal concentration of thrombin and factor XIII in plasma, or hemophilia. * Patients with significant co-morbidities, such as obesity, uncontrolled diabetes, immunosuppression, severe endocrine-induced bone diseases, signs of malnourishment, those receiving immunosuppressive therapy, poor tissue oxygenation or perfusion, and pre- or post-operative radiation. * Unable to give consent for participation.
Where it's running
-
University of Michigan School of Dentistry
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Study coordinator: Purnima Kumar, DDS, PhD
- Email: kpurnima@umich.edu
- Phone: 17347632105
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How Smoking Affects Immune Responses Around Dental Implants
This study tests how smoking changes the body's immune response around dental implants in people with healthy implants, peri-implant mucositis, or peri-implantitis.
-
AmbiJet-assisted treatment for inflamed dental implants
This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.
-
Non-surgical H42 treatment for peri-implant pockets
This study tests whether H42 can help heal peri-implant pockets compared with no-H42 care in adults with 6–8 mm pockets.
-
Macrophage behavior around dental implants in health and peri-implantitis
This study will test whether macrophage-related markers in tissue and fluids around dental implants differ between people with peri-implantitis and those with healthy implants, and whether smoking changes those markers.
-
Access to probing around dental implants
This multicenter study tests whether limited access to peri-implant probing is linked to more bone loss around dental implants in adults with implants in use for at least three years.
-
Two surgical treatments for peri-implantitis: implantoplasty versus mechanical debridement
This tests whether adding implantoplasty to resective surgery reduces inflammation and improves outcomes around dental implants in adults with peri-implantitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.